Alkermes plc (NASDAQ: ALKS) announced an increased offer to acquire Avadel Pharmaceuticals plc (NASDAQ: AVDL) for up to $22.50 per ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE